Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
rare disease drugs
2
×
san francisco blog main
acute migrane
astellas pharma
atlas venture
audentes therapeutics
avidity biosciences
bain capital
bausch health
bluebird bio
boston
boston blog main
boston top stories
breast cancer
desmoid tumor
dihydroergotamine
dihydroergotamine mesylate
duchenne muscular dystrophy
dyne therapeutics
facioscapulohumeral muscular dystrophy
gene therapy
generic drug
glaxosmithkline
impel neuropharma
joshua brumm
kaleido biosciences
medical device
migraine
multiple myeloma
muscular dystrophy
myotonic dystrophy type 1
national organization for rare disorders
national top stories
new york
new york top stories
What
drug
2
×
ipo
2
×
ipos
2
×
activity
ago
biotech
biotechs
companies
considering
data
days
diseases
dog
dyne
early
expected
experimental
eyes
firm
genetic
hasn’t
having
humans
leading
line
long
medicines
migraine
muscle
pfizer
place
prep
rare
reach
satsuma
securing
slowed
spinout
springworks
stopped
Language
unset
Current search:
ipos
×
ipo
×
" rare disease drugs "
×
drug
×
@xconomy.com
3 years ago
Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs